Oragenics Inc (OGEN)

Jun 13, 2026

OGEN Q2 2023 Earnings: EPS Beat on Lower-than-Expected Loss, But Stock DeclinesEarnings Forecast Report - newsline.com

Jun 13, 2026

Jun 13, 2026

OGEN Q2 2023 Earnings: Loss Narrower Than Expected but No Revenue, Stock DeclinesQuarterly Earnings Report - newsline.com

Jun 13, 2026

Jun 12, 2026

OGEN Q2 2023 Earnings: Narrower Loss Drives 5% Bounce on Surprise BeatRevenue Growth Report - newsline.com

Jun 12, 2026

Jun 11, 2026

OGEN Q2 2023 Earnings: Smaller-Than-Expected Loss as Clinical Pipeline ProgressesProduct Revenue Analysis - newsline.com

Jun 11, 2026

Jun 09, 2026

Oragenics Inc. (OGEN) Edges Lower to $0.60, Testing Key Support LevelsEarnings Quality Factor - newsline.com

Jun 09, 2026

Jun 09, 2026

OGEN Q2 2023 Earnings: EPS Beats Estimates by Over 50% as Company Advances PipelineBanking Earnings Report - newsline.com

Jun 09, 2026

Jun 09, 2026

OGEN News | ORAGENICS INC (NYSEARCA:OGEN) - ChartMill

Jun 09, 2026

Jun 05, 2026

ORAGENICS INC (OGEN) Stock Chart - ChartMill

Jun 05, 2026

May 29, 2026

Oragenics Inc. (OGEN) Inches Higher as Stock Tests Key Resistance Near $0.64SuperTrend Flip - newsline.com

May 29, 2026

May 26, 2026

Oragenics Inc. (OGEN) Slips Amid Low Volume, Hovers Near Key SupportIceberg Order - newsline.com

May 26, 2026

May 25, 2026

Oragenics Inc. (OGEN) Edges Higher as Biotech Volatility PersistsIceberg Order - The Legal Advocate

May 25, 2026

May 24, 2026

OGEN Q2 2023 Earnings: Narrower-than-Expected Loss Boosts Investor SentimentOpen Signal Network - Newser

May 24, 2026

May 24, 2026

OGEN | Oragenics Inc. Executive Compensation - Quiver Quantitative

May 24, 2026

May 24, 2026

Oragenics Q2 2023 Earnings: Narrowing Loss Surprises, No Revenue YetFull Year Guidance - Newser

May 24, 2026

May 20, 2026

Oragenics to Present at Sidoti's Micro-Cap Virtual Investor Conference May 20-21 - marketscreener.com

May 20, 2026

May 20, 2026

Oragenics (OGEN) Rallies +4.50% as Bulls Target $0.63 2026-05-20Community Buy Signals - Newser

May 20, 2026

May 19, 2026

Oragenics to Present at Sidoti Micro-Cap Virtual Investor Conference, Highlighting Progress on Concussion Treatment - MEXC

May 19, 2026

May 19, 2026

Oragenics Highlights Investor Outreach at Micro-Cap Conference - TipRanks

May 19, 2026

May 19, 2026

Oragenics to Present at Sidoti’s Micro-Cap Virtual Investor Conference May 20-21 - Yahoo Finance

May 19, 2026

May 19, 2026

Oragenics advances ONP-002 Phase IIa in Australia, $6.1M cash and LOI for CNS device - TradingView

May 19, 2026

May 19, 2026

ORAGENICS PROVIDES INVESTOR UPDATE - Sahm

May 19, 2026

May 18, 2026

Oragenics (OGEN) Q2 2023 Earnings Surprise: EPS $-1.51, Up SignificantBanking Earnings Report - Newser

May 18, 2026

May 18, 2026

Oragenics Advances Phase IIa Trial for Concussion Treatment, Eyes CNS Expansion - citybuzz -

May 18, 2026

May 18, 2026

Oragenics advances concussion drug trial, signs device LOI - Investing.com UK

May 18, 2026

May 18, 2026

Oragenics advances concussion drug trial, signs device LOI By Investing.com - Investing.com Nigeria

May 18, 2026

May 14, 2026

OGEN Technical Analysis | Trend, Signals & Chart Patterns | ORAGENICS INC (NYSEARCA:OGEN) - ChartMill

May 14, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 11, 2026

Oragenics (OGEN) continues pipeline investments amid losses; CEO discusses strategic priorities and funding outlook.Crowd Entry Points - Newser

May 11, 2026

May 08, 2026

Oragenics: Q1 Earnings Snapshot - 10tv.com

May 08, 2026

May 08, 2026

Oragenics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 08, 2026

May 08, 2026

Oragenics | 10-Q: Q1 2026 Earnings Report - Moomoo

May 08, 2026

May 07, 2026

Oragenics Signs LOI to License CardioDialysis Technology for Neurodegenerative Diseases - citybuzz -

May 07, 2026

May 07, 2026

Oragenics signs letter of intent to license blood purification tech - Investing.com

May 07, 2026

May 07, 2026

Oragenics signs letter of intent to license blood purification tech By Investing.com - Investing.com Australia

May 07, 2026

May 07, 2026

Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation - ChartMill

May 07, 2026

May 07, 2026

Oragenics IncSigns Letter Of Intent To License Cardiodialysis From Sigyn TherapeuticsSEC Filing - TradingView

May 07, 2026

May 07, 2026

Oragenics Signs Letter of Intent to License CardioDialysis™ - GlobeNewswire

May 07, 2026

May 06, 2026

Oragenics adds second site to concussion drug trial in Australia By Investing.com - Investing.com India

May 06, 2026

May 06, 2026

Oragenics Expands Phase IIa Trial for Concussion Treatment to Second Site - MEXC

May 06, 2026

May 05, 2026

Oragenics, Inc. Opens Second Clinical Site for Phase IIa Trial of ONP-002, Evaluating Treatment for Concussion with 60 Participants - geneonline.com

May 05, 2026

May 05, 2026

Oragenics adds second site to concussion drug trial in Australia - Investing.com

May 05, 2026

May 05, 2026

Oragenics Activates Second Site in Phase IIa Clinical Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury. - Yahoo Finance

May 05, 2026

Apr 27, 2026

Oragenics shares plunge following announcement of $20 million preferred stock sale - MSN

Apr 27, 2026